DRIVE IN BIO ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/8
2021
2021/8
2022
2022/8
2023
2023/8
2024
2024/8
Bankruptcy risk for industry  2.8% 2.8% 2.8% 2.8% 2.8%  
Bankruptcy risk  1.1% 3.1% 2.9% 1.6% 1.3%  
Credit score (0-100)  84 55 58 73 81  
Credit rating  A BBB BBB A A  
Credit limit (kDKK)  164.0 0.0 0.0 3.5 42.9  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/8
2021
2021/8
2022
2022/8
2023
2023/8
2024
2024/8

Net sales  0 0 0 0 0  
Gross profit  3,879 6,747 3,693 3,238 3,010  
EBITDA  1,138 3,228 531 1,066 1,066  
EBIT  980 3,100 436 994 981  
Pre-tax profit (PTP)  874.0 2,998.2 345.2 861.2 920.6  
Net earnings  677.3 2,334.8 265.2 655.5 712.9  
Pre-tax profit without non-rec. items  874 2,998 345 861 921  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/8
2021
2021/8
2022
2022/8
2023
2023/8
2024
2024/8

Tangible assets total  2,749 2,703 2,735 2,662 2,608  
Shareholders equity total  1,658 318 346 736 1,329  
Interest-bearing liabilities  1,769 1,611 1,555 1,311 661  
Balance sheet total (assets)  5,792 4,714 4,214 3,642 3,165  

Net Debt  -1,191 10.5 363 561 324  
 
See the entire balance sheet

Volume 
2020
2020/8
2021
2021/8
2022
2022/8
2023
2023/8
2024
2024/8

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  3,879 6,747 3,693 3,238 3,010  
Gross profit growth  16.7% 73.9% -45.3% -12.3% -7.0%  
Employees  3 3 4 3 3  
Employee growth %  50.0% 0.0% 33.3% -25.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  5,792 4,714 4,214 3,642 3,165  
Balance sheet change%  15.3% -18.6% -10.6% -13.6% -13.1%  
Added value  1,138.3 3,227.6 531.4 1,088.7 1,065.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -256 -203 -63 -145 -139  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2020
2020/8
2021
2021/8
2022
2022/8
2023
2023/8
2024
2024/8
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  25.3% 46.0% 11.8% 30.7% 32.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  18.1% 59.0% 10.1% 25.4% 29.3%  
ROI %  29.2% 114.0% 23.1% 49.2% 47.8%  
ROE %  45.5% 236.3% 79.9% 121.2% 69.0%  

Solidity 
2020
2020/8
2021
2021/8
2022
2022/8
2023
2023/8
2024
2024/8
Equity ratio %  28.6% 6.8% 8.2% 20.2% 42.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -104.6% 0.3% 68.3% 52.7% 30.4%  
Gearing %  106.7% 505.8% 449.8% 178.1% 49.7%  
Net interest  0 0 0 0 0  
Financing costs %  5.8% 6.0% 6.7% 9.6% 7.8%  

Liquidity 
2020
2020/8
2021
2021/8
2022
2022/8
2023
2023/8
2024
2024/8
Quick Ratio  1.2 0.9 0.6 0.6 0.3  
Current Ratio  1.2 0.9 0.6 0.6 0.3  
Cash and cash equivalent  2,960.1 1,600.1 1,191.7 749.8 336.3  

Capital use efficiency 
2020
2020/8
2021
2021/8
2022
2022/8
2023
2023/8
2024
2024/8
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  501.4 -240.3 -970.2 -673.5 -1,099.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/8
2021
2021/8
2022
2022/8
2023
2023/8
2024
2024/8
Net sales / employee  0 0 0 0 0  
Added value / employee  379 1,076 133 363 355  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  379 1,076 133 355 355  
EBIT / employee  327 1,033 109 331 327  
Net earnings / employee  226 778 66 218 238